Henry Ellenbogen
Durable Capital Partners
Henry Ellenbogen Medline Inc, CL-A stake
total: 158
Durable Capital Partners MDLN trades
- Total transactions:
- 3
- New positions:
- 1
- Added:
- 1
- Reduced:
- 1
- Held since:
- 2025 Q4
- Held for:
- 3 quarters
- Latest activity:
- 2026 Q2
According to 2026 Q2 report, Henry Ellenbogen holds 2,627,321 Medline Inc, CL-A (MDLN) shares with a market value of roughly $103.62M accounting for 1.01% of the overall portfolio. To date, the estimated cost basis is nearly $42.13 for "buy" trades and estimated average "sell" price is $39.44. Durable Capital Partners first purchased MDLN in 2025 Q4, initially acquiring about 6.90M shares. Since the initial investment in Medline Inc, CL-A (MDLN), Durable Capital Partners has made 2 more transactions.
When did Henry Ellenbogen buy Medline Inc, CL-A (MDLN)?
Henry Ellenbogen first invested in Medline Inc, CL-A (MDLN) in 2025 Q4 at the reported quarter-end price of $42.00 per share.
What's the cost basis of Durable Capital Partners's MDLN stake?
The estimated cost basis for Medline Inc, CL-A (MDLN) stake is around $42.13 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $42.13
- Weighted AVG sell price:
- $39.44
Henry Ellenbogen's historical trades in Medline Inc, CL-A
3 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
1.01%
|
2,627,321
|
$39.44
|
$103,621,540
|
-63.84% (-4,638,532)
|
-1.88%
|
|
2026 Q1
|
3.33%
|
7,265,853
|
$44.50
|
$323,330,459
|
+5.30% (+365,853)
|
+0.17%
|
|
2025 Q4
|
2.74%
|
6,900,000
|
$42.00
|
$289,800,000
|
new
|
+2.74%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.